Angiogenesis - Where do we stand now?

被引:338
作者
Simons, M
机构
[1] Dartmouth Coll Sch Med, Dartmouth Hitchcock Med Ctr, Cardiol Sect, Dept Med, Lebanon, NH 03756 USA
[2] Dartmouth Coll Sch Med, Dartmouth Hitchcock Med Ctr, Angiogenesis Res Ctr, Lebanon, NH 03756 USA
[3] Dartmouth Coll Sch Med, Dartmouth Hitchcock Med Ctr, Cardiol Sect, Dept Pharmacol & Toxicol, Lebanon, NH 03756 USA
关键词
angiogenesis; genetics; hypoxia; pharmacokinetics; imaging;
D O I
10.1161/01.CIR.0000159345.00591.8F
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Therapeutic modulation of angiogenesis is still in its infancy, but the baby is showing considerable potential. The ultimate success of this therapeutic modality will depend on careful translational research program that will incorporate the ever-evolving basic understanding of the biology of angiogenesis into an effective clinical trials program. The likely keys include the careful choice of a biological agent that may be different for different indications, effective delivery modality with pharmacokinetic properties matching biological needs, and the meticulous choice of patient population and end points for study. © 2005 American Heart Association, Inc.
引用
收藏
页码:1556 / 1566
页数:11
相关论文
共 119 条
[1]   VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J].
AIELLO, LP ;
AVERY, RL ;
ARRIGG, PG ;
KEYT, BA ;
JAMPEL, HD ;
SHAH, ST ;
PASQUALE, LR ;
THIEME, H ;
IWAMOTO, MA ;
PARK, JE ;
NGUYEN, HV ;
AIELLO, LM ;
FERRARA, N ;
KING, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1480-1487
[2]   Endothelial progenitor cells for postnatal vasculogenesis [J].
Asahara, T ;
Kawamoto, A .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2004, 287 (03) :C572-C579
[3]   LOCAL-DELIVERY OF VASCULAR ENDOTHELIAL GROWTH-FACTOR ACCELERATES REENDOTHELIALIZATION AND ATTENUATES INTIMAL HYPERPLASIA IN BALLOON-INJURED RAT CAROTID-ARTERY [J].
ASAHARA, T ;
BAUTERS, C ;
PASTORE, C ;
KEARNEY, M ;
ROSSOW, S ;
BUNTING, S ;
FERRARA, N ;
SYMES, JF ;
ISNER, JM .
CIRCULATION, 1995, 91 (11) :2793-2801
[4]   Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization [J].
Asahara, T ;
Masuda, H ;
Takahashi, T ;
Kalka, C ;
Pastore, C ;
Silver, M ;
Kearne, M ;
Magner, M ;
Isner, JM .
CIRCULATION RESEARCH, 1999, 85 (03) :221-228
[5]   Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic stimulus leading to enhancement of regional perfusion [J].
Babiak, A ;
Schumm, AM ;
Wangler, C ;
Loukas, M ;
Wu, JB ;
Dombrowski, S ;
Matuschek, C ;
Kotzerke, J ;
Dehio, C ;
Waltenberger, J .
CARDIOVASCULAR RESEARCH, 2004, 61 (04) :789-795
[6]   CD13/APN is activated by angiogenic signals and is essential for capillary tube formation [J].
Bhagwat, SV ;
Lahdenranta, J ;
Giordano, R ;
Arap, W ;
Pasqualini, R ;
Shapiro, LH .
BLOOD, 2001, 97 (03) :652-659
[7]   Coronary vascular morphology in pressure-overload left ventricular hypertrophy [J].
Bishop, SP ;
Powell, PC ;
Hasebe, NI ;
Shen, YT ;
Patrick, TA ;
Hittinger, L ;
Vatner, SF .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1996, 28 (01) :141-154
[8]   ACIDIC FIBROBLAST GROWTH-FACTOR PROMOTES VASCULAR REPAIR [J].
BJORNSSON, TD ;
DRYJSKI, M ;
TLUCZEK, J ;
MENNIE, R ;
RONAN, J ;
MELLIN, TN ;
THOMAS, KA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) :8651-8655
[9]   Vascular endothelial growth factor and its receptor, Flt-l, in the plasma of patients with coronary or peripheral atherosclerosis, or type II diabetes [J].
Blann, AD ;
Belgore, FM ;
McCollum, CN ;
Silverman, S ;
Lip, PL ;
Lip, GYH .
CLINICAL SCIENCE, 2002, 102 (02) :187-194
[10]   Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice [J].
Bråkenhielm, E ;
Cao, RH ;
Gao, BH ;
Angelin, B ;
Cannon, B ;
Parini, P ;
Cao, YH .
CIRCULATION RESEARCH, 2004, 94 (12) :1579-1588